Sook-Bin Woo, D.M.D., B.D.S.
Concepts
This page shows the publications Sook-Bin Woo has written about Diphosphonates.
Connection Strength
3.627
-
Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws. Biol Blood Marrow Transplant. 2016 Feb; 22(2):344-348.
Score: 0.409
-
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May; 109(5):753-64.
Score: 0.282
-
Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc. 2009 Jul; 140(7):864-75.
Score: 0.267
-
Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg. 2009 Mar; 67(3):593-601.
Score: 0.261
-
Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification". Oral Oncol. 2009 Aug; 45(8):740.
Score: 0.257
-
Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun; 105(6):e1-4.
Score: 0.246
-
Biophosphonate-related osteonecrosis of the jaws. Dent Clin North Am. 2008 Jan; 52(1):111-28, ix.
Score: 0.241
-
Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions. J Natl Cancer Inst. 2007 Jul 04; 99(13):986-7.
Score: 0.233
-
Osteonecrosis of the jaws and bisphosphonates. Alpha Omegan. 2007; 100(4):194-202.
Score: 0.225
-
Images in clinical medicine. Bisphosphonate-associated osteonecrosis of the jaw. N Engl J Med. 2006 Nov 30; 355(22):2348.
Score: 0.224
-
Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006 May 16; 144(10):753-61.
Score: 0.215
-
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005 Dec; 136(12):1658-68.
Score: 0.209
-
Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005 Jul 07; 353(1):99-102; discussion 99-102.
Score: 0.203
-
Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011; 16(1):121-32.
Score: 0.074
-
A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer. 2010 Aug; 18(8):1099-106.
Score: 0.071
-
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2008 Jun; 66(6):1320-1; author reply 1321-2.
Score: 0.062
-
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008 Apr 15; 14(8):2387-95.
Score: 0.061
-
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007 Oct; 22(10):1479-91.
Score: 0.059
-
Possible pathogenic engagement of soluble Semaphorin 4D produced by ?dT cells in medication-related osteonecrosis of the jaw (MRONJ). Biochem Biophys Res Commun. 2016 Nov 04; 480(1):42-47.
Score: 0.028
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.